The CD7 CAR)-T cell therapy has demonstrated potential in treating patients with relapsed or refractory T-cell leukaemia.

OnKure has announced the successful completion of its merger with Reneo Pharmaceuticals, forming the combined entity ...

RNA-based vaccines, which instruct cells to produce proteins that can prevent or treat disease, show great promise in ...

WuXi is considering the sale of some US and European operations to mitigate the impact of upcoming restrictions.

Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment ...

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

Teva Pharmaceuticals International and mAbxience have entered into a worldwide licencing agreement to develop an anti ...

Two years after the FDA placed partial clinical hold, Avidity can resume research of del-desiran as a treatment for myotonic ...

It is common for sponsors to switch digital platforms between clinical trial phases, but sponsors can achieve much by using ...

Bristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration (FDA) for Opdivo to treat adults ...

Amidst the long-running Cas9 patent battle, Editas Medicine has struck a deal to sell a portion of its future revenue stream ...

National Resilience’s subsidiary Resilience Government Services has received around $17.5m in funding for expanding critical ...